Although downstream effectors were tumor specific, NKILA mediated NF-κB abrogation in suppression of EMT was consistent in tongue squamous cell carcinoma [19], non-small cell lung cancer [21] and ESCC. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.